{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:37:41Z","timestamp":1788982661567,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pyoderma gangrenosum (PG) is a rarely diagnosed ulcerative neutrophilic dermatosis with unknown origin that has been poorly characterized in clinical studies so far. Consequently there have been significant discussions about its associated factors and comorbidities. The aim of our multicenter study was to analyze current data from patients in dermatologic wound care centers in Germany in order to describe associated factors and comorbidities in patients with PG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective clinical investigation of patients with PG from dermatologic wound care centers in Germany.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We received data from 259 patients with PG from 20 different dermatologic wound care centers in Germany. Of these 142 (54.8%) patients were female, 117 (45.2%) were male; with an age range of 21 to 95 years, and a mean of 58 years. In our patient population we found 45.6% with anemia, 44.8% with endocrine diseases, 12.4% with internal malignancies, 9.3% with chronic inflammatory bowel diseases and 4.3% with elevated creatinine levels. Moreover 25.5% of all patients had a diabetes mellitus with some aspects of potential association with the metabolic syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study describes one of the world\u2019s largest populations with PG. Beside the well-known association with chronic bowel diseases and neoplasms, a potentially relevant new aspect is an association with endocrine diseases, in particular the metabolic syndrome, thyroid dysfunctions and renal disorders. Our findings represent clinically relevant new aspects. This may help to describe the patients\u2019 characteristics and help to understand the underlying pathophysiology in these often misdiagnosed patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1750-1172-8-136","type":"journal-article","created":{"date-parts":[[2013,9,8]],"date-time":"2013-09-08T02:16:41Z","timestamp":1378606601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients"],"prefix":"10.1186","volume":"8","author":[{"given":"Philipp","family":"Al Ghazal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Herberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Str\u00f6lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman-Philipp","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Goerge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Karrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Maschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Eming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Wollina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Sick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benno","family":"Splieth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Dill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Klode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Dissemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,8]]},"reference":[{"issue":"6","key":"630_CR1","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1046\/j.1365-2133.1997.20022083.x","volume":"137","author":"P von den Driesch","year":"1997","unstructured":"von den Driesch P: Pyoderma gangrenosum: a report of 44 cases with follow up. Br J Dermatol. 1997, 137 (6): 1000-1005. 10.1111\/j.1365-2133.1997.tb01568.x.","journal-title":"Br J Dermatol"},{"key":"630_CR2","first-page":"173","volume":"55","author":"F Powell","year":"1985","unstructured":"Powell F, Schroeter A, Su W, Perry H: Pyoderma gangrenosum: a review of 86 patients. Q J Med. 1985, 55: 173-186.","journal-title":"Q J Med"},{"issue":"1","key":"630_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00005792-200001000-00004","volume":"79","author":"M Bennett","year":"2000","unstructured":"Bennett M, Jackson J, Jorizzo J, Fleischer A, White W, Callen J: Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000, 79 (1): 37-46. 10.1097\/00005792-200001000-00004.","journal-title":"Medicine (Baltimore)"},{"key":"630_CR4","unstructured":"Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M, et al: Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and sweet\u2019s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. in press."},{"issue":"1","key":"630_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1365-2249.2010.04201.x","volume":"162","author":"AV Marzano","year":"2010","unstructured":"Marzano AV, Cugno M, Trevisan V, Fanoni D, Venegoni L, Berti E, Crosti C: Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol. 2010, 162 (1): 100-107. 10.1111\/j.1365-2249.2010.04201.x.","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"630_CR6","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/jid.2012.130","volume":"132","author":"SM Langan","year":"2012","unstructured":"Langan SM, Groves RW, Card TR, Gulliford MC: Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012, 132 (9): 2166-2170. 10.1038\/jid.2012.130.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"630_CR7","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1365-2133.2007.08211.x","volume":"157","author":"TN Brooklyn","year":"2007","unstructured":"Brooklyn TN, Williams AM, Dunnill MG, Probert CS: T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking. Br J Dermatol. 2007, 157 (5): 960-966. 10.1111\/j.1365-2133.2007.08211.x.","journal-title":"Br J Dermatol"},{"issue":"2","key":"630_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1046\/j.1523-1747.1998.00311.x","volume":"111","author":"Y Adachi","year":"1998","unstructured":"Adachi Y, Kindzelskii AL, Cookingham G, Shaya S, Moore EC, Todd RF, Petty HR: Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol. 1998, 111 (2): 259-268. 10.1046\/j.1523-1747.1998.00311.x.","journal-title":"J Invest Dermatol"},{"issue":"9","key":"630_CR9","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/ajg.2009.271","volume":"104","author":"T Kawakami","year":"2009","unstructured":"Kawakami T, Yamazaki M, Soma Y: Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis. Am J Gastroenterol. 2009, 104 (9): 2363-2364. 10.1038\/ajg.2009.271.","journal-title":"Am J Gastroenterol"},{"key":"630_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1172-2-19","volume":"2","author":"U Wollina","year":"2007","unstructured":"Wollina U: Pyoderma gangrenosum - a review. Orphanet J Rare Dis. 2007, 2: 19. 10.1186\/1750-1172-2-19.","journal-title":"Orphanet J Rare Dis"},{"key":"630_CR11","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1002\/art.27521","volume":"62","author":"CL Cortesio","year":"2010","unstructured":"Cortesio CL, Wernimont SA, Kastner DL, Cooper KM, Huttenlocher A: Impaired podosome formation and invasive migration of macrophages from patients with a PSTPIP1 mutation and PAPA syndrome. Arthritis Rheum. 2010, 62: 2556-2558. 10.1002\/art.27521.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"630_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2174\/138920210793175921","volume":"11","author":"EJ Smith","year":"2010","unstructured":"Smith EJ, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, Kastner DL, Punaro M, Aksentijevich I, Pascual V, Wise CA: Clinical, molecular, and genetic characteristics of PAPA syndrome: a review. Curr Genomics. 2010, 11 (7): 519-527. 10.2174\/138920210793175921.","journal-title":"Curr Genomics"},{"issue":"5","key":"630_CR13","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","volume":"161","author":"M Brenner","year":"2009","unstructured":"Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P: Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol. 2009, 161 (5): 1199-1201. 10.1111\/j.1365-2133.2009.09404.x.","journal-title":"Br J Dermatol"},{"issue":"6","key":"630_CR14","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/art.34332","volume":"64","author":"AP Demidowich","year":"2012","unstructured":"Demidowich AP, Freeman AF, Kuhns DB, Aksentijevich I, Gallin JI, Turner ML, Kastner DL, Holland SM: Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum. 2012, 64 (6): 2022-2027. 10.1002\/art.34332.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"630_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","volume":"66","author":"M Braun-Falco","year":"2012","unstructured":"Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T: Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) - a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012, 66 (3): 409-415. 10.1016\/j.jaad.2010.12.025.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"630_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000343602","volume":"225","author":"AV Marzano","year":"2012","unstructured":"Marzano AV, Ishak RS, Colombo A, Caroli F, Crosti C: Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery. Dermatology. 2012, 225 (3): 215-219. 10.1159\/000343602.","journal-title":"Dermatology"},{"issue":"6","key":"630_CR17","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","volume":"149","author":"AV Marzano","year":"2013","unstructured":"Marzano AV, Trevisan V, Gattorno M, Ceccherini I, De Simone C, Crosti C: Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol. 2013, 149 (6): 762-764. 10.1001\/jamadermatol.2013.2907.","journal-title":"JAMA Dermatol"},{"issue":"6","key":"630_CR18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","volume":"165","author":"AM Binus","year":"2011","unstructured":"Binus AM, Qureshi AA, Li VW, Winterfield LS: Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities, and therapy in 103 patients. Br J Dermatol. 2011, 165 (6): 1244-1250. 10.1111\/j.1365-2133.2011.10565.x.","journal-title":"Br J Dermatol"},{"issue":"4","key":"630_CR19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1610-0387.2011.07734.x","volume":"10","author":"P Al Ghazal","year":"2012","unstructured":"Al Ghazal P, K\u00f6rber A, Klode J, Dissemond J: Investigation of new-cofactors in 49 patients with pyoderma gangrenosum. J Dtsch Dermatol Ges. 2012, 10 (4): 251-257.","journal-title":"J Dtsch Dermatol Ges"},{"key":"630_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(97)10187-8","volume":"351","author":"J Callen","year":"1998","unstructured":"Callen J: Pyoderma gangrenosum. Lancet. 1998, 351: 581-585. 10.1016\/S0140-6736(97)10187-8.","journal-title":"Lancet"},{"key":"630_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0190-9622(96)90428-4","volume":"34","author":"F Powell","year":"1996","unstructured":"Powell F, Su W, Perry H: Pyoderma gangrenosum: classification and management. J Am Acad Dermatol. 1996, 34: 395-409. 10.1016\/S0190-9622(96)90428-4.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"630_CR22","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1365-4632.2004.02128.x","volume":"43","author":"WP Su","year":"2004","unstructured":"Su WP, Davis MD, Weenig RH, Powell FC, Perry HO: Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004, 43 (11): 790-800. 10.1111\/j.1365-4632.2004.02128.x.","journal-title":"Int J Dermatol"},{"issue":"5","key":"630_CR23","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jaad.2010.01.049","volume":"64","author":"A Hadi","year":"2011","unstructured":"Hadi A, Lebwohl M: Clinical features of pyoderma gangrenosum and current diagnostic trends. J Am Acad Dermatol. 2011, 64 (5): 950-954. 10.1016\/j.jaad.2010.01.049.","journal-title":"J Am Acad Dermatol"},{"key":"630_CR24","first-page":"2207","volume-title":"Fitzpatrick\u2019s Dermatology in general medicine","author":"K Wolff","year":"1999","unstructured":"Wolff K, Stingl G: Pyoderma gangrenosum. Fitzpatrick\u2019s Dermatology in general medicine. 5 edition. Edited by: Freedberg IM, Eisen AZ, Wolff K. New York: Mc Graw-Hill; 1999: 2207-2213.","edition":"5"},{"issue":"42","key":"630_CR25","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1055\/s-0029-1242011","volume":"134","author":"U M\u00fcller-Ladner","year":"2009","unstructured":"M\u00fcller-Ladner U, Alten R, Heiligenhaus A, Kekow J, Koletzko S, Mrowietz U, Ochsenk\u00fchn T, Radke M, Reich K, Rudwaleit M, Schreiber S: \u201cTRECID\u201d, TNFalpha related chronic inflammatory diseases - a new multiple diseases bridging concept. Dtsch Med Wochenschr. 2009, 134 (42): 2132-2136. 10.1055\/s-0029-1242011.","journal-title":"Dtsch Med Wochenschr"},{"key":"630_CR26","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1365-4362.1992.tb02723.x","volume":"31","author":"CB Ko","year":"1992","unstructured":"Ko CB, Walton S, Wyatt EH: Pyoderma gangrenosum: associations revisited. Int J Dermatol. 1992, 31: 574-577. 10.1111\/j.1365-4362.1992.tb02723.x.","journal-title":"Int J Dermatol"},{"key":"630_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00000372-199302000-00005","volume":"15","author":"RM Hurwitz","year":"1993","unstructured":"Hurwitz RM, Haseman JH: The evolution of pyoderma gangrenosum: a clinicopathologic correlation. Am J Dermatopathol. 1993, 15: 28-33. 10.1097\/00000372-199302000-00005.","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"630_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3109\/09546631003686069","volume":"22","author":"AV Marzano","year":"2011","unstructured":"Marzano AV, Trevisan V, Lazzari R, Crosti C: Pyoderma gangrenosum: study of 21 patients and proposal of a \u2018clinicotherapeutic\u2019 classification. J Dermatolog Treat. 2011, 22 (5): 254-260. 10.3109\/09546631003686069.","journal-title":"J Dermatolog Treat"},{"key":"630_CR29","first-page":"415","volume":"1","author":"J Bolognia","year":"2003","unstructured":"Bolognia J, Jorizzo J, Rapini R: Pyoderma gangrenosum. Dermatology. 2003, 1: 415-418.","journal-title":"Dermatology"},{"issue":"7","key":"630_CR30","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/jid.2010.103","volume":"130","author":"B Davidovici","year":"2010","unstructured":"Davidovici B, Sattar N, Prinz J, Puig L, Emery P, Barker JN, van de Kerkhof P, Stahle M, Nestle FO, Girolomonis G, Krieger JG: Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010, 130 (7): 1785-1796. 10.1038\/jid.2010.103.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"630_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-0625.2009.00930.x","volume":"19","author":"B Poeggeler","year":"2010","unstructured":"Poeggeler B, Schulz C, Pappolla M: Leptin and the skin: a new frontier. Exp Dermatol. 2010, 19 (1): 12-18. 10.1111\/j.1600-0625.2009.00930.x.","journal-title":"Exp Dermatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-8-136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:19:38Z","timestamp":1630531178000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-8-136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,8]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-8-136","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,8]]},"assertion":[{"value":"20 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"136"}}